Endoglin in human liver disease and murine models of liver fibrosis : a protective factor against liver fibrosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1111/liv.13595
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2017
- Urheber
-
Alsamman, Muhammad
Sterzer, Viktor
Meurer, Steffen K.
Sahin, Hacer
Schäper, Ute
Kuscuoglu, Deniz
Strnad, Pavel
Weiskirchen, Ralf
Trautwein, Christian
Scholten, David
- DOI
-
10.18154/RWTH-CONV-219947
- URN
-
urn:nbn:de:101:1-2019082607451834186138
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:41 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Alsamman, Muhammad
- Sterzer, Viktor
- Meurer, Steffen K.
- Sahin, Hacer
- Schäper, Ute
- Kuscuoglu, Deniz
- Strnad, Pavel
- Weiskirchen, Ralf
- Trautwein, Christian
- Scholten, David
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2017
Ähnliche Objekte (12)
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Mechanisms of liver fibrosis resolution
Cellular Mechanisms of Liver Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Magnetic-Assisted Treatment of Liver Fibrosis
Magnetic-Assisted Treatment of Liver Fibrosis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Mechanisms of liver fibrosis resolution
Cellular Mechanisms of Liver Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Magnetic-Assisted Treatment of Liver Fibrosis
Magnetic-Assisted Treatment of Liver Fibrosis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Mechanisms of liver fibrosis resolution
Cellular Mechanisms of Liver Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Magnetic-Assisted Treatment of Liver Fibrosis
Magnetic-Assisted Treatment of Liver Fibrosis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation